Top Key Companies for Nuclear Medicine Diagnostic Equipment Market: GE HealthCare, Siemens Healthineers, Philips, Mediso Medical Imaging Systems, Digirad, Toshiba, Compañía Mexicana, SurgicEye, CMR Naviscan, DDD-Diagnostic, Positron, TeraRecon, Neusoft Group, United Imaging, MinFound Medical, SinoUnion Healthcare, Top Grade Healthcare.
Global Nuclear Medicine Diagnostic Equipment Market Size was estimated at USD 14606.81 million in 2022 and is projected to reach USD 36069.26 million by 2028, exhibiting a CAGR of 16.26% during the forecast period.
Global Nuclear Medicine Diagnostic Equipment Market Overview And Scope:
The Global Nuclear Medicine Diagnostic Equipment Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Nuclear Medicine Diagnostic Equipment utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Nuclear Medicine Diagnostic Equipment Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nuclear Medicine Diagnostic Equipment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Nuclear Medicine Diagnostic Equipment market.
Global Nuclear Medicine Diagnostic Equipment Market Segmentation
By Type, Nuclear Medicine Diagnostic Equipment market has been segmented into:
SPECT
PET
By Application, Nuclear Medicine Diagnostic Equipment market has been segmented into:
Tumor Imaging
Bone Marrow Imaging
Endocrine System Imaging
Urinary System Imaging
Others
Regional Analysis of Nuclear Medicine Diagnostic Equipment Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Nuclear Medicine Diagnostic Equipment Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Nuclear Medicine Diagnostic Equipment market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Nuclear Medicine Diagnostic Equipment market.
Top Key Companies Covered in Nuclear Medicine Diagnostic Equipment market are:
GE HealthCare
Siemens Healthineers
Philips
Mediso Medical Imaging Systems
Digirad
Toshiba
Compañía Mexicana
SurgicEye
CMR Naviscan
DDD-Diagnostic
Positron
TeraRecon
Neusoft Group
United Imaging
MinFound Medical
SinoUnion Healthcare
Top Grade Healthcare
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Nuclear Medicine Diagnostic Equipment Market by Type
5.1 Nuclear Medicine Diagnostic Equipment Market Overview Snapshot and Growth Engine
5.2 Nuclear Medicine Diagnostic Equipment Market Overview
5.3 SPECT
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 SPECT: Geographic Segmentation
5.4 PET
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 PET: Geographic Segmentation
Chapter 6: Nuclear Medicine Diagnostic Equipment Market by Application
6.1 Nuclear Medicine Diagnostic Equipment Market Overview Snapshot and Growth Engine
6.2 Nuclear Medicine Diagnostic Equipment Market Overview
6.3 Tumor Imaging
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Tumor Imaging: Geographic Segmentation
6.4 Bone Marrow Imaging
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Bone Marrow Imaging: Geographic Segmentation
6.5 Endocrine System Imaging
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Endocrine System Imaging: Geographic Segmentation
6.6 Urinary System Imaging
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Urinary System Imaging: Geographic Segmentation
6.7 Others
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Nuclear Medicine Diagnostic Equipment Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Nuclear Medicine Diagnostic Equipment Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Nuclear Medicine Diagnostic Equipment Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 GE HEALTHCARE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 SIEMENS HEALTHINEERS
7.4 PHILIPS
7.5 MEDISO MEDICAL IMAGING SYSTEMS
7.6 DIGIRAD
7.7 TOSHIBA
7.8 COMPAÑÍA MEXICANA
7.9 SURGICEYE
7.10 CMR NAVISCAN
7.11 DDD-DIAGNOSTIC
7.12 POSITRON
7.13 TERARECON
7.14 NEUSOFT GROUP
7.15 UNITED IMAGING
7.16 MINFOUND MEDICAL
7.17 SINOUNION HEALTHCARE
7.18 TOP GRADE HEALTHCARE
Chapter 8: Global Nuclear Medicine Diagnostic Equipment Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 SPECT
8.2.2 PET
8.3 Historic and Forecasted Market Size By Application
8.3.1 Tumor Imaging
8.3.2 Bone Marrow Imaging
8.3.3 Endocrine System Imaging
8.3.4 Urinary System Imaging
8.3.5 Others
Chapter 9: North America Nuclear Medicine Diagnostic Equipment Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 SPECT
9.4.2 PET
9.5 Historic and Forecasted Market Size By Application
9.5.1 Tumor Imaging
9.5.2 Bone Marrow Imaging
9.5.3 Endocrine System Imaging
9.5.4 Urinary System Imaging
9.5.5 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Nuclear Medicine Diagnostic Equipment Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 SPECT
10.4.2 PET
10.5 Historic and Forecasted Market Size By Application
10.5.1 Tumor Imaging
10.5.2 Bone Marrow Imaging
10.5.3 Endocrine System Imaging
10.5.4 Urinary System Imaging
10.5.5 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Nuclear Medicine Diagnostic Equipment Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 SPECT
11.4.2 PET
11.5 Historic and Forecasted Market Size By Application
11.5.1 Tumor Imaging
11.5.2 Bone Marrow Imaging
11.5.3 Endocrine System Imaging
11.5.4 Urinary System Imaging
11.5.5 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Nuclear Medicine Diagnostic Equipment Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 SPECT
12.4.2 PET
12.5 Historic and Forecasted Market Size By Application
12.5.1 Tumor Imaging
12.5.2 Bone Marrow Imaging
12.5.3 Endocrine System Imaging
12.5.4 Urinary System Imaging
12.5.5 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Nuclear Medicine Diagnostic Equipment Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 SPECT
13.4.2 PET
13.5 Historic and Forecasted Market Size By Application
13.5.1 Tumor Imaging
13.5.2 Bone Marrow Imaging
13.5.3 Endocrine System Imaging
13.5.4 Urinary System Imaging
13.5.5 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Nuclear Medicine Diagnostic Equipment Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 SPECT
14.4.2 PET
14.5 Historic and Forecasted Market Size By Application
14.5.1 Tumor Imaging
14.5.2 Bone Marrow Imaging
14.5.3 Endocrine System Imaging
14.5.4 Urinary System Imaging
14.5.5 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Nuclear Medicine Diagnostic Equipment Scope:
|
Report Data
|
Nuclear Medicine Diagnostic Equipment Market
|
|
Nuclear Medicine Diagnostic Equipment Market Size in 2025
|
USD XX million
|
|
Nuclear Medicine Diagnostic Equipment CAGR 2025 - 2032
|
XX%
|
|
Nuclear Medicine Diagnostic Equipment Base Year
|
2024
|
|
Nuclear Medicine Diagnostic Equipment Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
GE HealthCare, Siemens Healthineers, Philips, Mediso Medical Imaging Systems, Digirad, Toshiba, Compañía Mexicana, SurgicEye, CMR Naviscan, DDD-Diagnostic, Positron, TeraRecon, Neusoft Group, United Imaging, MinFound Medical, SinoUnion Healthcare, Top Grade Healthcare.
|
|
Key Segments
|
By Type
SPECT
PET
By Applications
Tumor Imaging
Bone Marrow Imaging
Endocrine System Imaging
Urinary System Imaging
Others
|
